E-LIB Suche - Ergebnisse für: Toshiki Masuishi

1

Sotorasib with panitumumab in chemotherapy-refractory KRASG..:

Kuboki, Yasutoshi ; Fakih, Marwan ; Strickler, John...
Nature Medicine. 30 (2024) 1 - p. 265-270 , 2024

Link: https://doi.org/10.1038/..

2

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuxi..:

Kotani, Daisuke ; Takashima, Atsuo ; Kato, Takeshi...
Clinical Colorectal Cancer. 23 (2024) 2 - p. 174-182.e6 , 2024

Link: https://doi.org/10.1016/..

3

QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFO..:

Bando, Hideaki ; Kotani, Daisuke ; Satake, Hironaga...
Med. , 2024

Link: https://doi.org/10.1016/..

4

Survival impact of sequential chemotherapy following pembro..:

Iwaki, Sho ; Kadowaki, Shigenori ; Honda, Kazunori...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 764-770 , 2024

Link: https://doi.org/10.1007/..

5

Chronological improvement of survival in patients with adva..:

Ogata, Takatsugu ; Narita, Yukiya ; Oze, Isao...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

6

Risk factors affecting delay of initiating adjuvant chemoth..:

Maeda, Shingo ; Ouchi, Akira ; Komori, Koji...
International Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1007/..

7

Trifluridine/tipiracil with and without ramucirumab for adv..:

Narita, Yukiya ; Ogata, Takatsugu ; Ishizuka, Yasunobu...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trif..:

Matsumoto, Toshihiko ; Yamamoto, Yoshiyuki ; Kotaka, Masahito...
Targeted Oncology. 19 (2024) 2 - p. 181-190 , 2024

Link: https://doi.org/10.1007/..

9

A Phase II Trial of Trifluridine/Tipiracil in Combination w..:

Izawa, Naoki ; Masuishi, Toshiki ; Takahashi, Naoki...
Targeted Oncology. 18 (2023) 3 - p. 369-381 , 2023

Link: https://doi.org/10.1007/..

10

Fruquintinib versus placebo in patients with refractory met..:

Dasari, Arvind ; Lonardi, Sara ; Garcia-Carbonero, Rocio...
The Lancet. 402 (2023) 10395 - p. 41-53 , 2023

Link: https://doi.org/10.1016/..

11

Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiraci..:

Taniguchi, Hiroya ; Yamazaki, Kentaro ; Masuishi, Toshiki...
The Oncologist. 28 (2023) 11 - p. e1108-e1113 , 2023

Link: https://doi.org/10.1093/..

12

Differential Efficacy of Targeted Monoclonal Antibodies in ..:

Kodama, Hiroyuki ; Masuishi, Toshiki ; Wakabayashi, Munehiro...
Clinical Colorectal Cancer. 22 (2023) 3 - p. 298-306 , 2023

Link: https://doi.org/10.1016/..

13

Final results of DESTINY-CRC01 investigating trastuzumab de..:

Yoshino, Takayuki ; Di Bartolomeo, Maria ; Raghav, Kanwal...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

First experience of a fully decentralized clinical trial: T..:

Taniguchi, Hiroya ; Masuishi, Toshiki ; Ogata, Takatsugu...
Cancer Science. 114 (2023) 7 - p. 3050-3052 , 2023

Link: https://doi.org/10.1111/..

15

Randomised phase II trial of trifluridine/tipiracil (FTD/TP..:

Takahashi, Naoki ; Hara, Hiroki ; Nagashima, Kengo...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..